Gilead Sciences stock loses 0.04 percent pre-market to EUR 134.45
Published on 10/13/2026 at 07:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Gilead Sciences stock is at EUR 134.45 in pre-market trading.
- The price is 0.04 percent below the October 12 Xetra close.
- BofA Securities raised its reported target to USD 164.00 on October 12.
Gilead Sciences stock is at EUR 134.45 in pre-market trading at Lang & Schwarz on October 13, 2026, at 7:43 a.m. CEST. That is 0.04 percent below the Xetra close of October 12, 2026, at EUR 134.50.
Gilead Sciences before the Xetra open
The Lang & Schwarz bid was EUR 133.96 and the ask was EUR 134.94 at the quoted time. The Xetra session is scheduled to begin at 9:00 a.m. CEST. The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of Gilead Sciences stock.
What matters today
Xetra trading is scheduled to resume at 9:00 a.m. CEST on October 13, 2026. A move to the next round level of EUR 135.00 would represent a gain of 0.41 percent from the Lang & Schwarz price. BofA Securities' October 12, 2026 report cited a USD 164.00 price target, raised from USD 162.00, while maintaining its Buy rating.
Investing.com also reported BofA's estimates for third-quarter product sales, including USD 3.922 billion for Biktarvy compared with a consensus estimate of USD 3.908 billion. The report was published on October 12, 2026.
Market context: Market report Nasdaq Composite.
